Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms

Ceftazidime-avibactam (CAZ-AVI) is a recently approved β-lactam–β-lactamase inhibitor combination with the potential to treat serious infections caused by carbapenem-resistant organisms. Few patients with such infections were included in the CAZ-AVI clinical trials, and clinical experience is lackin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Temkin, Elizabeth, Torre-Cisneros, Julian, Beovic, Bojana, Benito, Natividad, Giannella, Maddalena, Gilarranz, Raúl, Jeremiah, Cameron, Loeches, Belén, Machuca, Isabel, Jiménez-Martín, María José, Martínez, José Antonio, Mora-Rillo, Marta, Navas, Enrique, Osthoff, Michael, Pozo, Juan Carlos, Ramos Ramos, Juan Carlos, Rodriguez, Marina, Sánchez-García, Miguel, Viale, Pierluigi, Wolff, Michel, Carmeli, Yehuda
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278727/
https://ncbi.nlm.nih.gov/pubmed/27895014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01964-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars